BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19629648)

  • 21. Protective Effects of Sesquiterpenoids from the Root of Panax ginseng on Fulminant Liver Injury Induced by Lipopolysaccharide/d-Galactosamine.
    Wang W; Zhang Y; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J
    J Agric Food Chem; 2018 Jul; 66(29):7758-7763. PubMed ID: 29974747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does high mobility group 1 protein function as a late mediator for LPS- or TNF-induced shock in galactosamine-sensitized mice?
    Hasunuma R; Maruyama H; Takimoto H; Ryll R; Tanaka S; Kumazawa Y
    J Endotoxin Res; 2002; 8(5):391-8. PubMed ID: 12537698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genipin protects lipopolysaccharide-induced apoptotic liver damage in D-galactosamine-sensitized mice.
    Kim SJ; Kim JK; Lee DU; Kwak JH; Lee SM
    Eur J Pharmacol; 2010 Jun; 635(1-3):188-93. PubMed ID: 20303938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of 26-kDa cell-associated TNF-alpha in experimental hepatitis and exacerbation of liver injury with a matrix metalloproteinase inhibitor.
    Solorzano CC; Ksontini R; Pruitt JH; Hess PJ; Edwards PD; Kaibara A; Abouhamze A; Auffenberg T; Galardy RE; Vauthey JN; Copeland EM; Edwards CK; Lauwers GY; Clare-Salzler M; MacKay SL; Moldawer LL; Lazarus DD
    J Immunol; 1997 Jan; 158(1):414-9. PubMed ID: 8977217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant human soluble thrombomodulin improved lipopolysaccharide/d-galactosamine-induced acute liver failure in mice.
    Osumi W; Jin D; Imai Y; Tashiro K; Li ZL; Otsuki Y; Maemura K; Komeda K; Hirokawa F; Hayashi M; Takai S; Uchiyama K
    J Pharmacol Sci; 2015 Dec; 129(4):233-9. PubMed ID: 26712705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of complement activation in tumour necrosis factor-induced lethal hepatitis.
    Libert C; Wielockx B; Grijalba B; Van Molle W; Kremmer E; Colten HR; Fiers W; Brouckaert P
    Cytokine; 1999 Aug; 11(8):617-25. PubMed ID: 10433810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Echinacoside ameliorates D-galactosamine plus lipopolysaccharide-induced acute liver injury in mice via inhibition of apoptosis and inflammation.
    Li X; Gou C; Yang H; Qiu J; Gu T; Wen T
    Scand J Gastroenterol; 2014 Aug; 49(8):993-1000. PubMed ID: 24797709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secoisolariciresinol and isotaxiresinol inhibit tumor necrosis factor-alpha-dependent hepatic apoptosis in mice.
    Banskota AH; Nguyen NT; Tezuka Y; Le Tran Q; Nobukawa T; Kurashige Y; Sasahara M; Kadota S
    Life Sci; 2004 Apr; 74(22):2781-92. PubMed ID: 15043992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement by galactosamine of lipopolysaccharide(LPS)-induced tumour necrosis factor production and lethality: its suppression by LPS pretreatment.
    Endo Y; Shibazaki M; Yamaguchi K; Kai K; Sugawara S; Takada H; Kikuchi H; Kumagai K
    Br J Pharmacol; 1999 Sep; 128(1):5-12. PubMed ID: 10498828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. D-galactosamine-induced mouse hepatic apoptosis: possible involvement with tumor necrosis factor, but not with caspase-3 activity.
    Itokazu Y; Segawa Y; Inoue N; Omata T
    Biol Pharm Bull; 1999 Oct; 22(10):1127-30. PubMed ID: 10549870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Herbal formula CGX ameliorates LPS/D-galactosamine-induced hepatitis.
    Shin JW; Wang JH; Park HJ; Choi MK; Kim HG; Son CG
    Food Chem Toxicol; 2011 Jun; 49(6):1329-34. PubMed ID: 21414374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TNF-alpha but not IL-1alpha is correlated with PGE1-dependent protection against acute D-galactosamine-induced liver injury.
    Muntané J; Montero JL; Lozano JM; Miranda-Vizuete A; de La Mata M; Miño G
    Can J Gastroenterol; 2000 Mar; 14(3):175-80. PubMed ID: 10758413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effect of chloral hydrate against lipopolysaccharide/D-galactosamine-induced acute lethal liver injury and zymosan-induced peritonitis in mice.
    Pan Q; Liu Y; Zheng J; Lu X; Wu S; Zhu P; Fu N
    Int Immunopharmacol; 2010 Aug; 10(8):967-77. PubMed ID: 20669364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochanin A protects lipopolysaccharide/D-galactosamine-induced acute liver injury in mice by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation.
    Liu X; Wang T; Liu X; Cai L; Qi J; Zhang P; Li Y
    Int Immunopharmacol; 2016 Sep; 38():324-31. PubMed ID: 27344638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunomodulatory activity of TNF-alpha during acute liver injury induced by D-galactosamine and its protection by PGE1 in rats.
    Lozano JM; Padillo J; Montero JL; Peña J; De la Mata M; Muntané J
    Int Immunopharmacol; 2003 Feb; 3(2):197-207. PubMed ID: 12586601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic effects of antibodies against high-mobility group box 1 and tumor necrosis factor-α antibodies on D-(+)-galactosamine hydrochloride/lipopolysaccharide-induced acute liver failure.
    Wang W; Sun L; Deng Y; Tang J
    FEBS J; 2013 Mar; 280(6):1409-19. PubMed ID: 23331758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatoprotection by human epidermal growth factor (hEGF) against experimental hepatitis induced by D-galactosamine (D-galN) or D-GalN/lipopolysaccharide.
    Cho JY; Yeon JD; Kim JY; Yoo ES; Yu YH; Park MH
    Biol Pharm Bull; 2000 Oct; 23(10):1243-6. PubMed ID: 11041260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of globin digest and its active ingredient Trp-Thr-Gln-Arg on galactosamine/lipopolysaccharide-induced liver injury in ICR mice.
    Sasakawa Y; Kominami A; Yamamoto K; Nakaoka F; Nakamura M; Nakao M; Abe M; Fukuhama C; Kagawa K
    Life Sci; 2012 Jan; 90(5-6):190-9. PubMed ID: 22154906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ornithine and histidine decarboxylase activities in mice sensitized to endotoxin, interleukin-1 or tumour necrosis factor by D-galactosamine.
    Endo Y; Kikuchi T; Nakamura M
    Br J Pharmacol; 1992 Nov; 107(3):888-94. PubMed ID: 1472981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective blockade of mGlu5 metabotropic glutamate receptors is hepatoprotective against fulminant hepatic failure induced by lipopolysaccharide and D-galactosamine in mice.
    Jesse CR; Wilhelm EA; Bortolatto CF; Savegnago L; Nogueira CW
    J Appl Toxicol; 2009 May; 29(4):323-9. PubMed ID: 19153979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.